Jabou Tech

Anti Cancer Drugs


China is preparing to expand the number of cancer drugs for which patients can be reimbursed under national government-backed health insurance plans, with price negotiations scheduled to finish by the end of September, state media reported.

The new state medical insurance administration, which was set up in May, has identified drugs used to treat cancers — including non-small cell lung cancer, renal cell carcinoma and melanoma — for inclusion on the reimbursement list, the official Xinhua News Agency said (link in Chinese).